Provided by Tiger Trade Technology Pte. Ltd.

Novartis AG

140.15
-0.9050-0.64%
Volume:1.52M
Turnover:213.92M
Market Cap:267.40B
PE:21.19
High:141.57
Open:141.45
Low:139.95
Close:141.05
52wk High:170.46
52wk Low:121.57
Shares:1.91B
Float Shares:1.85B
Volume Ratio:1.01
T/O Rate:0.08%
Dividend:4.67
Dividend Rate:3.33%
EPS(TTM):6.61
EPS(LYR):7.15
ROE:30.35%
ROA:10.25%
PB:6.44
PE(LYR):19.60

Loading ...

Novartis Bets $7.8 Billion On MRNA Beyond Vaccines

Options & Short Sell
·
Yesterday

Novartis AG Falls Friday, Underperforms Market

Dow Jones
·
2 hours ago

Dow Jones Top Company Headlines at 11 am ET: Tesla Sales Slump in Third Quarter | David ...

Dow Jones
·
Yesterday

Novartis to License Drug from China's Abogen in up to $7.8 Billion Deal

Dow Jones
·
Yesterday

Major Drugmakers Turn to China for Licensing Deals

Reuters
·
Yesterday

Novartis, Abogen Sign RNA Licensing Agreement Worth up to $7.2 Billion

MT Newswires Live
·
Yesterday

Novartis AG Falls Wednesday, Outperforms Market

Dow Jones
·
Oct 01

Novartis AG Rises Monday, Outperforms Market

Dow Jones
·
Sep 29

Novartis AG Rises Friday, Outperforms Market

Dow Jones
·
Sep 26

Pharmaceutical Stocks Jump. Moderna, Eli Lilly up over 3%; Novavax, Pfizer up Around 2%; Merck, Novo Nordisk up over 1%

Tiger Newspress
·
Sep 24

Novartis Poised for Sales Growth Acceleration

Dow Jones
·
Sep 24

Novartis AG Rises Wednesday, Outperforms Market

Dow Jones
·
Sep 24

European Pharma Leaders Push for National Reforms to Boost Investment

Dow Jones
·
Sep 22

Novartis AG Rises Monday, Underperforms Market

Dow Jones
·
Sep 22

Novartis AG Falls Friday, Outperforms Market

Dow Jones
·
Sep 19

Novartis announces positive CHMP opinion for Cosentyx

TIPRANKS
·
Sep 18

Novartis Halts ALS Drug Development After Phase 2 Trial Miss

MT Newswires Live
·
Sep 17

Novartis AG Rises Wednesday

Dow Jones
·
Sep 17

Novartis to End ALS Trial Amid String of Study Failures

Dow Jones
·
Sep 16

Legend Biotech Taps Novartis Veteran Zhang as CEO

Reuters
·
Sep 15